 interview, Debra Goff, PharmD, FIDSA, FCCP, infectious diseases specialist at the Ohio State University Wexner Medical Center and professor of Pharmacy Practice at the Ohio State University College of Pharmacy, reviews what makes Clostridioides difficile (C. diff) awareness critical, and highlights the work of the Peggy Lillis Foundation.

In this discussion, Goff covers the risk factors for contracting C. diff, current available treatments, and the future of C. diff treatment. She also details the efforts of the Peggy Lillis Foundation to raise awareness of this disease.

Videos

Debra Goff, PharmD, FIDSA, FCCP, infectious diseases specialist at the Ohio State University Wexner Medical Center, discusses Clostridioides difficile awareness and potential future treatments.

Expert Discusses the Importance of C. Diff Awareness, Future Treatments

Minority researchers and investigators from underrepresented communities often have access to less clinical research funding than other clinical researchers, according to Barbara Goodman, MBA, president and CEO of Cures Within Reach.

In an interview with Pharmacy Times, Goodman said new funding from the organization is aiming to improve these access issues specifically for clinical trials of repurposed drugs. Because repurposing trials often have fewer hurdles than de novo trials, the much-needed treatments could reach patients sooner. In order to support this research, Goodman said Cures Within Reach is in the process of selecting researchers to fund, both in the United States and internationally, and those selections will be completed by the end of the year.

Minority researchers and investigators from underrepresented communities often have access to less clinical research funding than other clinical researchers.

New Funding Opportunities Support Researchers, Communities of Color

 interview, Nicole Ross, MSN, CRNP, AOCNP, nurse practitioner for the department of hematology/oncology​ at Fox Chase Cancer Center, about her presentation on neuroendocrine tumor (NETs) management in large cancer centers at the NANETS 2021 Conference.

She discussed the challenges of treating NETs in large cancer centers.

Nicole Ross, MSN, CRNP, AOCNP, nurse practitioner for the department of hematology/oncology​ at Fox Chase Cancer Center, discusses the challenges of treating  neuroendocrine tumors in large cancer centers.

Expert Discusses Challenges of Treating Individuals at Large Cancer Centers


She discussed how large cancer centers are able to manage adverse events for individuals with NETs.

Nicole Ross, MSN, CRNP, AOCNP, nurse practitioner for the department of hematology/oncology​ at Fox Chase Cancer Center, discusses how large cancer centers are able to manage adverse events for individuals with neuroendocrine tumors.

Expert Discusses How Large Cancer Centers Manage Adverse Events for Individuals With Neuroendocrine Tumor 

 interview, Paolo Raggi, MD, PhD, professor at the department of medicine in the division of cardiology at the University of Alberta, about his ASN 2021 Kidney Week presentation on the prevention of vascular calcification in chronic kidney disease (CKD).

He discussed the cardiovascular effects of CKD.

Paolo Raggi, MD, PhD, professor at the department of medicine in the division of cardiology at the University of Alberta, discusses the cardiovascular effects of chronic kidney disease.

Expert Discusses Cardiovascular Effects of CKD

She discussed how large cancer centers are able to manage care for individuals with many different physicians.

Nicole Ross, MSN, CRNP, AOCNP, nurse practitioner for the department of hematology/oncology​ at Fox Chase Cancer Center, discusses how large cancer centers are able to manage care for individuals with many different physicians.

Many Physicians at Large Cancer Centers Help Manage Care for Individuals With Neuroendocrine Tumor

He discussed how pharmacists are limited to traditional treatment of CKD, while waiting for new treatment options.

Paolo Raggi, MD, PhD, professor at the department of medicine in the division of cardiology at the University of Alberta, discusses how pharmacists are limited to traditional treatment of chronic kidney disease, while waiting for new treatment options.

Expert Discusses Limitations of Vascular Calcification Treatments

He discussed promising new crystallization treatment of vascular calcification.

Paolo Raggi, MD, PhD, professor at the department of medicine in the division of cardiology at the University of Alberta, discusses promising new crystallization treatment of vascular calcification.

Expert Discusses New Crystallization Treatment of Vascular Calcification

She discussed the importance of pharmacists in helping treat individuals with NETs.

Nicole Ross, MSN, CRNP, AOCNP, nurse practitioner for the department of hematology/oncology​ at Fox Chase Cancer Center, discusses the importance of pharmacists in helping treat individuals with neuroendocrine tumors.

Oncology Pharmacists Play a Huge Role in Caring for Individuals With Neuroendocrine Tumor

 interview, Kaushal Nanavati, MD, FAAFP, ABOIM, ABIHM assistant dean of wellness and director of integrative medicine and survivorship at the Upstate Cancer Center, spoke about his 2021 NANETS presentation on the integrative management of neuroendocrine tumors (NETs).

He discussed the different treatment options that could help individuals with NETs, emphasizing the importance of nutrition.

Kaushal Nanavati, MD, assistant dean of wellness and director of integrative medicine and survivorship at the Upstate Cancer Center discusses the different treatment options that could help individuals with neuroendocrine tumors, emphasizing the importance of nutrition.

Interviews